PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32723256-6 2021 Additionally, HO-AAVPA reduced the number of vessels in chorioallantoid membranes (CAMs) by approximately 67.74% and IL-6 levels in both cell lines suggesting that the biochemical mechanism on cancer cell of HO-AAVPA is different compared to VPA. Valproic Acid 19-22 interleukin 6 Homo sapiens 117-121 32782515-0 2020 Sodium valproate combined with levetiracetam in pediatric epilepsy and its influence on NSE, IL-6, hs-CRP and electroencephalogram improvement. Valproic Acid 0-16 interleukin 6 Homo sapiens 93-97 32782515-1 2020 Efficacy of sodium valproate combined with levetiracetam (LEV) in pediatric epilepsy and its influence on neuron-specific enolase (NSE), interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) as well as electroencephalogram (EEG) improvement were studied. Valproic Acid 12-28 interleukin 6 Homo sapiens 137-150 32782515-8 2020 In the treatment of pediatric epilepsy, sodium valproate combined with LEV produces better efficacy, fewer adverse reactions, significantly improves patients" QOL and notably lowers the content of NSE, IL-6 and hs-CRP with notable EEG improvement, so it is a safe and reliable treatment that is worth popularization. Valproic Acid 40-56 interleukin 6 Homo sapiens 202-206 24757498-2 2014 Recent in vitro and animal studies of valproic acid (VPA) report antioxidative and anti-inflammatory properties, and suppression of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha. Valproic Acid 38-51 interleukin 6 Homo sapiens 132-150 31785814-5 2020 Interestingly, the combination treatment of VPA and anti-PD-L1 antibody activated IRF1/IRF8 transcriptional axis in MDSCs leading to blockade of their immunosuppressive function by downregulating the expression of IL-10, IL-6, and ARG1 while re-activating CD8+ T-cells for the production of TNFalpha to further enhance anti-tumor immunity. Valproic Acid 44-47 interleukin 6 Homo sapiens 221-225 27639185-5 2017 VPA and lithium both induce significant down-regulation of group I CD1 expression and secretion of IL-6 during differentiation of human monocyte-derived immature DC, while they differ in the induction of CD83 and CD86 expression, secretion of IL-8, IL-10, and TNF-alpha. Valproic Acid 0-3 interleukin 6 Homo sapiens 99-103 24742998-4 2014 METHODS AND RESULTS: We showed that VPA inhibited the production of IFN-alpha and the proinflammatory cytokines TNF-alpha and IL-6 by CpG-activated PDC. Valproic Acid 36-39 interleukin 6 Homo sapiens 126-130 24757498-2 2014 Recent in vitro and animal studies of valproic acid (VPA) report antioxidative and anti-inflammatory properties, and suppression of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha. Valproic Acid 53-56 interleukin 6 Homo sapiens 132-150 21866484-8 2011 In vitro and in vivo experiments show that antiepileptic drugs could affect cytokine levels (e.g. valproate significantly inhibited production of TNF- alpha and IL-6 by human monocytic leukaemia cells). Valproic Acid 98-107 interleukin 6 Homo sapiens 161-165 34635175-11 2021 The production of inflammatory cytokines (TNF-alpha and IL-6) induced by TNF-alpha and SARS-CoV-2 infection is diminished in the presence of VPA. Valproic Acid 141-144 interleukin 6 Homo sapiens 56-60 16192836-0 2005 Effect of valproate on plasma levels of interleukin-6 in healthy male humans. Valproic Acid 10-19 interleukin 6 Homo sapiens 40-53 16192836-2 2005 The present study aimed to determine whether there is a treatment effect of valproate on plasma levels of the pro-inflammatory cytokine, interleukin (IL)-6, in healthy male humans. Valproic Acid 76-85 interleukin 6 Homo sapiens 137-155 16192836-3 2005 Plasma levels of IL-6 were measured in 10 healthy male humans before and after 7 days of treatment with 1000 mg per day of valproate (i.e. 500 mg in the morning and 500 mg in the evening). Valproic Acid 123-132 interleukin 6 Homo sapiens 17-21 16192836-9 2005 We found a significant increase in plasma levels of IL-6 after the 7 days of valproate treatment in healthy male subjects. Valproic Acid 77-86 interleukin 6 Homo sapiens 52-56 16192836-10 2005 Furthermore, there was a significant positive correlation between the changes in plasma IL-6 and blood levels of valproic acid. Valproic Acid 113-126 interleukin 6 Homo sapiens 88-92 16192836-11 2005 The findings of this study are consistent with previous studies on subjects with epilepsy, suggesting a modulating effect of valproate on the pro-inflammatory cytokine IL-6 in humans. Valproic Acid 125-134 interleukin 6 Homo sapiens 168-172 19205364-13 2008 In vitro valproate inhibits TNFa and IL-6 production, whereas in epileptic patients this drug enhances IL-1, IL-6 and IL-5 concentration. Valproic Acid 9-18 interleukin 6 Homo sapiens 37-41 12807426-5 2003 We found that VPA dose-dependently inhibited SP-induced IL-6 synthesis which was seen with pre-incubation periods of 30 min, 3, 7 and 14 days, whereas carbamazepine and lithium showed no inhibitory effect. Valproic Acid 14-17 interleukin 6 Homo sapiens 56-60 10700573-0 2000 Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Valproic Acid 0-16 interleukin 6 Homo sapiens 54-58 10700573-8 2000 VPA significantly inhibited LPS-induced production of TNF-alpha and IL-6 by THP-1 cells, whereas other AEDs did not. Valproic Acid 0-3 interleukin 6 Homo sapiens 68-72 10700573-9 2000 The findings are consistent with the idea that VPA suppresses TNF-alpha and IL-6 production via inhibition of NF-kappaB activation. Valproic Acid 47-50 interleukin 6 Homo sapiens 76-80 34630611-8 2021 After treatment, the levels of NSE, MBP, TNF-alpha, and IL-6 in the two groups decreased, and the levels of BDNF increased, and the LEV group changed significantly compared with the VPA group (P < 0.05). Valproic Acid 182-185 interleukin 6 Homo sapiens 56-60 34122007-9 2021 Meanwhile, VPA reduced dMCAo-induced elevation of IL-6 at 24 h post-stroke and significantly decreased the number of CD11b-positive microglia within peri-infarct cortex at 7 days. Valproic Acid 11-14 interleukin 6 Homo sapiens 50-54